R & T (Lee) Clinic Limited 11316493 false 2024-05-01 2025-04-30 2025-04-30 The principal activity of the company is Dental Practice Activities Digita Accounts Production Advanced 6.30.9574.0 true true 11316493 2024-05-01 2025-04-30 11316493 2025-04-30 11316493 bus:OrdinaryShareClass1 2025-04-30 11316493 core:CurrentFinancialInstruments 2025-04-30 11316493 core:CurrentFinancialInstruments core:WithinOneYear 2025-04-30 11316493 core:Non-currentFinancialInstruments core:AfterOneYear 2025-04-30 11316493 core:FurnitureFittings 2025-04-30 11316493 core:LandBuildings core:ShortLeaseholdAssets 2025-04-30 11316493 core:MotorVehicles 2025-04-30 11316493 core:PlantMachinery 2025-04-30 11316493 bus:SmallEntities 2024-05-01 2025-04-30 11316493 bus:AuditExemptWithAccountantsReport 2024-05-01 2025-04-30 11316493 bus:FilletedAccounts 2024-05-01 2025-04-30 11316493 bus:SmallCompaniesRegimeForAccounts 2024-05-01 2025-04-30 11316493 bus:RegisteredOffice 2024-05-01 2025-04-30 11316493 bus:Director1 2024-05-01 2025-04-30 11316493 bus:Director2 2024-05-01 2025-04-30 11316493 bus:OrdinaryShareClass1 2024-05-01 2025-04-30 11316493 bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 11316493 bus:Agent1 2024-05-01 2025-04-30 11316493 core:Goodwill 2024-05-01 2025-04-30 11316493 core:FurnitureFittings 2024-05-01 2025-04-30 11316493 core:LandBuildings core:ShortLeaseholdAssets 2024-05-01 2025-04-30 11316493 core:MotorVehicles 2024-05-01 2025-04-30 11316493 core:PlantMachinery 2024-05-01 2025-04-30 11316493 countries:England 2024-05-01 2025-04-30 11316493 2024-04-30 11316493 core:FurnitureFittings 2024-04-30 11316493 core:LandBuildings core:ShortLeaseholdAssets 2024-04-30 11316493 core:MotorVehicles 2024-04-30 11316493 core:PlantMachinery 2024-04-30 11316493 2023-05-01 2024-04-30 11316493 2024-04-30 11316493 bus:OrdinaryShareClass1 2024-04-30 11316493 core:CurrentFinancialInstruments 2024-04-30 11316493 core:CurrentFinancialInstruments core:WithinOneYear 2024-04-30 11316493 core:Non-currentFinancialInstruments core:AfterOneYear 2024-04-30 11316493 core:FurnitureFittings 2024-04-30 11316493 core:LandBuildings core:ShortLeaseholdAssets 2024-04-30 11316493 core:MotorVehicles 2024-04-30 11316493 core:PlantMachinery 2024-04-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 11316493

R & T (Lee) Clinic Limited

Unaudited Filleted Abridged Financial Statements

for the Year Ended 30 April 2025

 

R & T (Lee) Clinic Limited

Contents

Company Information

1

Abridged Balance Sheet

2

Notes to the Unaudited Abridged Financial Statements

3 to 8

 

R & T (Lee) Clinic Limited

Company Information

Directors

Dr S Raajanathan

Dr T Selvadurai

Registered office

74 Pitfold Road
Lee
London
SE12 9HY

Accountants

DJM Accountants & Consultancy Limited 71-75 Shelton Street
Covent Garden
London
WC2H 9JQ

 

R & T (Lee) Clinic Limited

(Registration number: 11316493)
Abridged Balance Sheet as at 30 April 2025

Note

2025
£

2024
£

Fixed assets

 

Intangible assets

4

381,345

401,415

Tangible assets

5

400,406

164,292

 

781,751

565,707

Current assets

 

Stocks

6

30,240

-

Debtors

200

200

Cash at bank and in hand

 

1,357

20,463

 

31,797

20,663

Creditors: Amounts falling due within one year

(116,550)

(98,430)

Net current liabilities

 

(84,753)

(77,767)

Total assets less current liabilities

 

696,998

487,940

Creditors: Amounts falling due after more than one year

(543,450)

(410,733)

Net assets

 

153,548

77,207

Capital and reserves

 

Called up share capital

7

2

2

Retained earnings

153,546

77,205

Shareholders' funds

 

153,548

77,207

For the financial year ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 24 April 2026 and signed on its behalf by:
 

Dr S Raajanathan
Director

   
     
 

R & T (Lee) Clinic Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2025

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
74 Pitfold Road
Lee
London
SE12 9HY

These financial statements were authorised for issue by the Board on 24 April 2026.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

R & T (Lee) Clinic Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2025

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery

10% on reducing balance

Fixtures and fittings

10% on reducing balance

Motor vehicle

15% on reducing balance

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Goodwill

Amortised over 25 years

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

 

R & T (Lee) Clinic Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2025

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

R & T (Lee) Clinic Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2025

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 6 (2024 - 5).

4

Intangible assets

Total
£

Cost or valuation

At 1 May 2024

501,765

At 30 April 2025

501,765

Amortisation

At 1 May 2024

100,350

Amortisation charge

20,070

At 30 April 2025

120,420

Carrying amount

At 30 April 2025

381,345

At 30 April 2024

401,415

 

R & T (Lee) Clinic Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2025

5

Tangible assets

Short leasehold land and buildings
£

Fixtures and fittings
£

Plant and machinery
£

Motor vehicles
 £

Cost or valuation

At 1 May 2024

-

104,796

114,399

37,500

Additions

19,939

122,189

137,540

-

At 30 April 2025

19,939

226,985

251,939

37,500

Depreciation

At 1 May 2024

-

40,158

37,774

14,471

Charge for the year

-

18,683

21,417

3,454

At 30 April 2025

-

58,841

59,191

17,925

Carrying amount

At 30 April 2025

19,939

168,144

192,748

19,575

At 30 April 2024

-

64,638

76,625

23,029

Total
£

Cost or valuation

At 1 May 2024

256,695

Additions

279,668

At 30 April 2025

536,363

Depreciation

At 1 May 2024

92,403

Charge for the year

43,554

At 30 April 2025

135,957

Carrying amount

At 30 April 2025

400,406

At 30 April 2024

164,292

Included within the net book value of land and buildings above is £19,939 (2024 - £Nil) in respect of short leasehold land and buildings.
 

 

R & T (Lee) Clinic Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2025

6

Stocks

2025
£

2024
£

Other inventories

30,240

-

7

Share capital

Allotted, called up and fully paid shares

2025

2024

No.

£

No.

£

Ordinary shares of £1 each

2

2

2

2